Pacific Shuanglin Bio-pharmacy Co., Ltd. (SHE:000403)
China flag China · Delayed Price · Currency is CNY
13.49
-0.15 (-1.10%)
Feb 13, 2026, 3:04 PM CST

SHE:000403 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Jan '22 Jan '21
12,82115,44819,95716,66920,54018,713
Market Cap Growth
-18.05%-22.60%19.73%-18.85%9.77%112.54%
Enterprise Value
12,61114,28318,99015,72519,92818,927
Last Close Price
13.4916.0020.3316.9120.7828.17
PE Ratio
22.6720.7332.6028.3952.52100.62
Forward PE
12.7220.9020.9020.9036.4065.38
PS Ratio
5.385.828.576.9310.4217.82
PB Ratio
1.601.952.692.433.2519.35
P/TBV Ratio
2.463.024.344.115.8520.80
P/FCF Ratio
--66.14114.50250.30120.99
P/OCF Ratio
-48.0129.3931.8050.3296.04
EV/Sales Ratio
5.295.388.156.5410.1118.03
EV/EBITDA Ratio
17.7215.6324.6422.3237.0469.09
EV/EBIT Ratio
21.1318.0129.9726.7946.3283.53
EV/FCF Ratio
-26.43-62.94108.02242.85122.38
Debt / Equity Ratio
0.130.080.070.050.020.39
Debt / EBITDA Ratio
1.450.710.640.520.261.39
Debt / FCF Ratio
--1.642.571.722.46
Net Debt / Equity Ratio
-0.02-0.12-0.18-0.15-0.150.29
Net Debt / EBITDA Ratio
-0.29-1.04-1.76-1.49-1.821.01
Net Debt / FCF Ratio
0.434.77-4.50-7.21-11.921.79
Asset Turnover
0.260.300.280.320.450.71
Inventory Turnover
0.901.261.471.691.801.27
Quick Ratio
1.562.422.702.462.670.66
Current Ratio
2.933.743.723.183.851.35
Return on Equity (ROE)
7.07%9.71%8.56%8.91%10.73%20.66%
Return on Assets (ROA)
4.00%5.55%4.77%4.87%6.13%9.60%
Return on Invested Capital (ROIC)
6.80%10.63%9.48%9.36%11.15%18.64%
Return on Capital Employed (ROCE)
7.20%9.60%8.20%8.40%6.70%21.90%
Earnings Yield
4.37%4.83%3.07%3.52%1.90%0.99%
FCF Yield
-3.72%-1.29%1.51%0.87%0.40%0.83%
Dividend Yield
2.85%2.40%0.76%0.36%0.21%-
Payout Ratio
67.40%35.50%10.91%8.46%3.08%96.17%
Buyback Yield / Dilution
0.80%-0.28%0.33%-3.38%-44.25%-0.21%
Total Shareholder Return
3.62%2.12%1.08%-3.02%-44.04%-0.21%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.